{"brief_title": "Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)", "brief_summary": "The purpose of this study is to determine if therapy with pioglitazone or vitamin E will lead to an improvement in liver histology in non-diabetic adult patients with non-alcoholic steatohepatitis (NASH).", "detailed_description": "The purpose of this study is to determine if therapy with pioglitazone or vitamin E will lead to an improvement in liver histology in non-diabetic adult patients with non-alcoholic steatohepatitis (NASH).", "condition": ["Liver Diseases"], "intervention_type": ["Drug", "Dietary Supplement", "Drug"], "intervention_name": ["Pioglitazone", "Vitamin E", "Matching placebo"], "description": ["30 mg daily", "800 IU daily", "Daily"], "arm_group_label": ["1", "2", "3"], "other_name": ["Actos", "Nature Made"], "criteria": "- Histologic evidence of NASH based on a liver biopsy obtained within 6 months of randomization. - Age 18 years or older", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Steatohepatitis", "mesh_term": ["Liver Diseases", "Fatty Liver", "Non-alcoholic Fatty Liver Disease", "Vitamins", "Vitamin E", "Tocopherols", "Tocotrienols", "alpha-Tocopherol", "Pioglitazone"], "id": "NCT00063622"}